Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Lowell Sears Insider Profile
4 Followers
Lowell Sears, Director at Immunic, holds 58.57K shares in Immunic (Ticker: IMUX), holds 35.71K shares in Paratek Pharmaceuticals (Ticker: PRTK). Most recently, Lowell Sears Bought ― shares of Immunic on Oct 08, 2014 for an estimated value of 25.01K.
Profitable Transactions
1 out of 2 Profitable Transactions
Average Return
+33.60%
Average return per transaction
Time Frame
Compare to
Insider Roles
Director
Roles that Lowell Sears holds in companies
Most Profitable Insider Trade
The most profitable trade made by Lowell Sears
Lowell Sears's Trading History
Immunic
Oct 08, 2014
Director
Informative Buy
25.01K
$80.83K
Paratek Pharmaceuticals
―
―
―
$79.64K
List of latest transactions for each holding click on a transaction to see Lowell Sears's performance on stock
You May Also Like
Lowell Sears insider profile FAQ
What is the percentage of profitable transactions made by Lowell Sears?
The percentage of profitable transactions made by Lowell Sears is 50%.
What is the average return per transaction made by Lowell Sears?
The average return per transaction made by Lowell Sears is 33.60%.
What stocks does Lowell Sears hold?
Lowell Sears holds: IMUX, PRTK stocks.
What was Lowell Sears’s latest transaction?
Lowell Sears latest transaction was an Informative Buy of $25.01K.
What was Lowell Sears's most profitable transaction?
Lowell Sears’s most profitable transaction was an Informative Buy of IMUX stock on April 23, 2014. The return on the trade was 138.20%.
What is Lowell Sears's role in Immunic?
Lowell Sears's role in Immunic is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.